-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, HuqHfeLU2Q3FbU3Sp0Mw/2wLxor/sJ0szGbfHSydf60Or+JHslnLSmDNNg87HHCc yN6nuXACYjkXq1fhFMOEoQ== 0000892569-08-000893.txt : 20080617 0000892569-08-000893.hdr.sgml : 20080617 20080616185543 ACCESSION NUMBER: 0000892569-08-000893 CONFORMED SUBMISSION TYPE: RW PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20080617 DATE AS OF CHANGE: 20080616 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIOLASE TECHNOLOGY INC CENTRAL INDEX KEY: 0000811240 STANDARD INDUSTRIAL CLASSIFICATION: DENTAL EQUIPMENT & SUPPLIES [3843] IRS NUMBER: 870442441 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: RW SEC ACT: SEC FILE NUMBER: 333-129995 FILM NUMBER: 08901592 BUSINESS ADDRESS: STREET 1: 4 CROMWELL CITY: IRVINE STATE: CA ZIP: 92618 BUSINESS PHONE: 949-361-1200 MAIL ADDRESS: STREET 1: 4 CROMWELL CITY: IRVINE STATE: CA ZIP: 92618 FORMER COMPANY: FORMER CONFORMED NAME: LASER MEDICAL TECHNOLOGY INC DATE OF NAME CHANGE: 19941117 FORMER COMPANY: FORMER CONFORMED NAME: LASER ENDO TECHNIC CORP DATE OF NAME CHANGE: 19920708 FORMER COMPANY: FORMER CONFORMED NAME: PAMPLONA CAPITAL CORP DATE OF NAME CHANGE: 19911104 RW 1 a41499rw.htm FORM RW rw
Biolase Technology, Inc.
4 Cromwell
Irvine, CA 92618
Telephone: (888) 424-6527
Facsimile: (949) 366-3325
June 11, 2008
VIA EDGAR AND OVERNIGHT DELIVERY
Ms. Peggy Fisher
Assistant Director
Division of Corporation Finance
United States Securities and Exchange Commission
100 F Street N.E.
Washington, D.C. 20549
Dear Ms. Fisher:
     On November 29, 2005, Biolase Technology, Inc., a Delaware corporation (the “Company”), filed a Registration Statement on Form S-1 (File No. 333-129995) (together with the exhibits and amendments thereto, the “Registration Statement”) under the Securities Act of 1933, as amended (the “Securities Act”), with the Securities and Exchange Commission (the “Commission”). Pursuant to Rule 477 under the Securities Act, the Company hereby requests that the Commission consent to the withdrawal of the Registration Statement effective as of the date hereof or at the earliest practicable date hereafter. The Company is requesting such withdrawal because it had filed a subsequent Registration Statement on Form S-3 on March 19, 2007 (File No. 333-141417) under the Securities Act that registered a portion of the shares covered by the Registration Statement. With respect to the unregistered portion, the Company is no longer obligated to register those shares. The Registration Statement has not been declared effective by the Commission and no securities have been issued or sold under the Registration Statement. Therefore, withdrawal of the Registration Statement is consistent with the public interest and the protection of investors, as contemplated by Rule 477(a).
     Please send copies of the written order granting withdrawal of the Registration Statement to the undersigned at Biolase Technology, Inc., 4 Cromwell, Irvine, California 92618, facsimile number (949) 366-3325, with a copy to the Company’s counsel, Latham & Watkins LLP, 650 Town Center Drive, 20th Floor, Costa Mesa, California, 92626, Attn: William Cernius, facsimile number (714) 755-8290.
     Please do not hesitate to contact me directly if you have any questions regarding this matter.
         
  Very truly yours,

Biolase Technology, Inc.
 		  
  By:   /s/ Jake St. Philip    
    Name:   Jake St. Philip   
    Title:   Chief Executive Officer   
 

-----END PRIVACY-ENHANCED MESSAGE-----